ダウンロード数: 210
このアイテムのファイル:
ファイル | 記述 | サイズ | フォーマット | |
---|---|---|---|---|
66_2_49.pdf | 852.19 kB | Adobe PDF | 見る/開く |
完全メタデータレコード
DCフィールド | 値 | 言語 |
---|---|---|
dc.contributor.author | 弓場, 覚 | ja |
dc.contributor.author | 中山, 雅志 | ja |
dc.contributor.author | 栗林, 宗平 | ja |
dc.contributor.author | 辻, 博隆 | ja |
dc.contributor.author | 波多野, 浩士 | ja |
dc.contributor.author | 中井, 康友 | ja |
dc.contributor.author | 垣本, 健一 | ja |
dc.contributor.author | 西村, 和郎 | ja |
dc.contributor.alternative | Yumiba, Satoru | en |
dc.contributor.alternative | Nakayama, Masashi | en |
dc.contributor.alternative | Kuribayashi, Sohei | en |
dc.contributor.alternative | Tsuji, Hirotaka | en |
dc.contributor.alternative | Hatano, Koji | en |
dc.contributor.alternative | Nakai, Yasutomo | en |
dc.contributor.alternative | Kakimoto, Ken-ichi | en |
dc.contributor.alternative | Nishimura, Kazuo | en |
dc.contributor.transcription | ユミバ, サトル | ja-Kana |
dc.contributor.transcription | ナカヤマ, マサシ | ja-Kana |
dc.contributor.transcription | クリバヤシ, ソウヘイ | ja-Kana |
dc.contributor.transcription | ツジ, ヒロタカ | ja-Kana |
dc.contributor.transcription | ハタノ, コウジ | ja-Kana |
dc.contributor.transcription | ナカイ, ヤストモ | ja-Kana |
dc.contributor.transcription | カキモト, ケンイチ | ja-Kana |
dc.contributor.transcription | ニシムラ, カズオ | ja-Kana |
dc.date.accessioned | 2020-03-12T23:46:03Z | - |
dc.date.available | 2020-03-12T23:46:03Z | - |
dc.date.issued | 2020-02-29 | - |
dc.identifier.issn | 0018-1994 | - |
dc.identifier.uri | http://hdl.handle.net/2433/246177 | - |
dc.description.abstract | A 64-year-old man was diagnosed with metastatic prostate cancer (cT3bN0M1b) and treated with combined androgen blockade. After two years and three months, he developed castration-resistant prostate cancer. Multiple lung metastases appeared after the administration of five courses of docetaxel and four courses of cabazitaxel therapy. Pulmonary metastases disappeared following rechallenge with docetaxel. Enzalutamide administration was initiated because docetaxel had to be discontinued due to adverse events. Although enzalutamide lowered the prostate specific antigen value, the patient staggered while walking and developed homonymous hemianopsia. Magnetic resonance imaging revealed a brain tumor. Although the brain tumor was considered to have metastasized from the prostate cancer, it was diagnosed as a primary central nervous system lymphoma using open-ended tumor biopsy. The brain tumor was eliminated with whole-brain irradiation. Thereafter, he has been treated with enzalutamide for 3 years without clinical progression of either disease. | en |
dc.format.mimetype | application/pdf | - |
dc.language.iso | jpn | - |
dc.publisher | 泌尿器科紀要刊行会 | ja |
dc.rights | 許諾条件により本文は2021/03/01に公開 | ja |
dc.subject | Brain metastasis of prostate cancer | en |
dc.subject | Primary central nervous system lymphoma | en |
dc.subject.ndc | 494.9 | - |
dc.title | 去勢抵抗性前立腺癌治療中に発症した中枢神経原発悪性リンパ腫の1例 | ja |
dc.title.alternative | A Case of Primary Central Nervous System Lymphoma that Developed during the Treatment of Castration-Resistant Prostate Cancer | en |
dc.type | departmental bulletin paper | - |
dc.type.niitype | Departmental Bulletin Paper | - |
dc.identifier.ncid | AN00208315 | - |
dc.identifier.jtitle | 泌尿器科紀要 | ja |
dc.identifier.volume | 66 | - |
dc.identifier.issue | 2 | - |
dc.identifier.spage | 49 | - |
dc.identifier.epage | 52 | - |
dc.textversion | publisher | - |
dc.sortkey | 04 | - |
dc.address | 大阪国際がんセンター泌尿器科 | ja |
dc.address | 大阪国際がんセンター泌尿器科 | ja |
dc.address | 大阪国際がんセンター泌尿器科 | ja |
dc.address | 大阪国際がんセンター泌尿器科 | ja |
dc.address | 大阪国際がんセンター泌尿器科 | ja |
dc.address | 大阪国際がんセンター泌尿器科 | ja |
dc.address | 大阪国際がんセンター泌尿器科 | ja |
dc.address | 大阪国際がんセンター泌尿器科 | ja |
dc.address.alternative | The Department of Urology, Osaka International Cancer Institute | en |
dc.address.alternative | The Department of Urology, Osaka International Cancer Institute | en |
dc.address.alternative | The Department of Urology, Osaka International Cancer Institute | en |
dc.address.alternative | The Department of Urology, Osaka International Cancer Institute | en |
dc.address.alternative | The Department of Urology, Osaka International Cancer Institute | en |
dc.address.alternative | The Department of Urology, Osaka International Cancer Institute | en |
dc.address.alternative | The Department of Urology, Osaka International Cancer Institute | en |
dc.address.alternative | The Department of Urology, Osaka International Cancer Institute | en |
dc.identifier.pmid | 32160733 | - |
dc.identifier.selfDOI | 10.14989/ActaUrolJap_66_2_49 | - |
dcterms.accessRights | open access | - |
datacite.date.available | 2021-03-01 | - |
dc.identifier.pissn | 0018-1994 | - |
dc.identifier.jtitle-alternative | Acta urologica Japonica | la |
dc.identifier.jtitle-alternative | Hinyokika Kiyo | en |
出現コレクション: | Vol.66 No.2 |
このリポジトリに保管されているアイテムはすべて著作権により保護されています。